Worst performing NASDAQ stocks for 2019 YTD - down 81%. With a $2.00 target by 1-1-20 No rebound Perhaps some capitulation with swings if 10% based on volume of speculation buyers not institutional investors and certainly not for core business performance. You launched, and set a sub par trajectory for the future, you failed, you rebated too heavily out of desperation, you GTN is poor. Take it out back and shoot it, or divest to a real company at $6 share and dance in the street about you stock doubling... when that happens you are still the losers.
WHAT A HIT JOB THIS POST IS !!!!!! Acorda is on track for a record REBOUND. Wall Street pros see the target of 17-22 by 2Q2020 !! This will make many rank&file investors very very wealthy indeed. There is an ole saying "Rome was not built in a day" So it is Acorda has had ups and some downs and we are now on REBOUND !! Great Leadership, product, workers and a yuge international market as we have 170mil who should be in PD meds !! Lets GO GO GO !!!!!!!!!!!!!!!!
$17 is great .. . You would have to get back to $40 to break even for all the shareholderS that bought in way back when u were around 40. The fact u focus on R&F becoming wealthy is just another example you being self focused SLUGS. BTW... anyone can rebound after you colossal market losses under your leadership. You have nowhere to go but up... but still holding on your $2.00 share by Q2 2020. Someone in your rank and file will inevitably F#%?! up and further dilute your GTN, with a deep disc to Pbm just to quote coverage on your investor call.. Acorda is more predictable with screw up than performance. Can anyone say: API supply issues?
Number one you cannot spell. Number 2… only fools and delusional people stay here. The company has failed and the entire C suite should be fired. This company will fold in 4 months. Just watch.
